Reimagine what's essential.
Refocus what's attainable.
Rethink what's possible.

As our world continues to change in the midst of the global COVID-19 pandemic, we have a profound opportunity to shift the infectious disease paradigm—and a vital responsibility to lead the charge.

It's time to counter confusion with clarity.

Introducing the Infectious Disease Council.

An international coalition of interdisciplinary experts representing the fields of pandemic infectious disease policy, healthcare, education, medical diagnostics and testing, and law have formed the InfectiousDisease Council to help organizations and individuals strike back against COVID-19.

Work Smart. Work Safe. Work Well.

African American man in antiviral mask gesturing thumb up during coronavirus vaccination, approving of covid-19 immunization. Young doctor giving vaccine injection to male patient

COVID-19 Vaccination: When Will the U.S. Reach Herd Immunity?

Three COVID-19 vaccines produced by Pfizer, Moderna and Johnson & Johnson have all received emergency use authorization in the United States and a mass vaccination program is now underway. The vaccines are all very safe and effective, and as of the beginning of April 2021 more than 108 million people have received at least one…
Herd immunity of most people of population protecting all against virus concept visualized with geometrical hexagon grid background 3D rendering

How do we reach herd immunity?

Herd immunity is population–level protection against the spread of an infectious disease that is based on pre–existing immunity of a high proportion of individuals in that population, either from prior infection or vaccination. The idea of herd immunity also acknowledges the need to protect a small proportion of our population who cannot be vaccinated for…
A female medical student attending a school lecture raises her hand to ask a question. The multi-ethnic group of adult students is wearing medical scrubs and protective face masks to prevent viral infection during the Covid-19 pandemic.

Risk of Coronavirus Transmission in Classrooms, Clinical Settings, and the Community

Many colleges are reopening for in–person learning after major shutdowns during the spring and fall of 2020 to mitigate transmission of the novel coronavirus. Reopening is especially important for nursing education because there is already a substantial nurse shortage both in the United States and globally (Snavely 2016). An important question is whether nurses and…
Multi-ethnic group of students wearing protective face masks while sitting in a lecture hall sitting 2 meters apart.

Vaccine Requirements in Higher Education: Managing Vaccine Proof and Waivers

Most colleges and universities won’t be in a position to require all members of their communities to be vaccinated against COVID-19 until at least summer or fall of 2021. As of December 2020, vaccines are being made available under FDA Emergency Use Authorizations (EUAs), and federal law requires that recipients of products permitted under EUAs…

Risk Factors Associated With SARS–CoV–2 Seropositivity Among US Health Care Personnel

Since coronavirus disease 2019 (COVID-19) was recognized in the United States in January 2020, the risk of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) attributed to exposures in the health care workplace has been studied with conflicting results.
Three young active friends jogging together with protective face masks on.

A Clear Path Forward Must Exist for Those Who Can Receive the COVID-19 Vaccine and Those Who Cannot

In December 2020, the U.S. Food and Drug Administration approved two brands of the COVID-19 vaccine, produced by Pfizer and Moderna, for emergency use authorization. A third vaccine, made by Johnson and Johnson, received the same authorization in February 2021. With this authorization, and the ensuing nationwide vaccine rollout, millions of individuals across the nation…